• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罂粟碱加前列腺素E1与单独使用前列腺素E1用于体内注射治疗的比较

Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.

作者信息

Zaher T F

机构信息

Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Int Urol Nephrol. 1998;30(2):193-6. doi: 10.1007/BF02550576.

DOI:10.1007/BF02550576
PMID:9607891
Abstract

PURPOSE

A study comparing intracorporeal injection of prostaglandin E1 (one-drug solution) and papaverine plus prostaglandin E1 (2-drug solution) for treatment of impotence.

MATERIALS AND METHODS

A total of 100 impotent patients had intracorporeal injections of the one-drug and 2-drug solution alternatively in 3 sessions. The quality and duration of erections were assessed.

RESULTS

Seventy-five per cent of the patients developed full erection with the 2-drug solution compared to 50% with the one-drug solution. The average duration of erections was 60 minutes and 45 minutes, respectively. The complication rate was higher for the 2-drug solution.

CONCLUSION

Papaverine plus prostaglandin E1 is superior to prostaglandin E1 alone for treatment of impotence, but has a higher rate of complications. Intracavemous injection of vasoactive drugs is a very effective and important way for treatment of impotence. Papaverine plus prostaglandin E1 had been used for treatment of impotence alone or combined. A blind study was done to compare efficiency and complication rates of intracavemous injection of papaverine plus prostaglandin E1 (2-drug solution) with prostaglandin E1 alone.

摘要

目的

一项比较前列腺素E1体内注射(单药溶液)和罂粟碱加前列腺素E1(双药溶液)治疗阳痿的研究。

材料与方法

总共100例阳痿患者在3个疗程中交替进行单药溶液和双药溶液的体内注射。对勃起的质量和持续时间进行评估。

结果

使用双药溶液的患者中有75%出现完全勃起,而使用单药溶液的患者中这一比例为50%。勃起的平均持续时间分别为60分钟和45分钟。双药溶液的并发症发生率更高。

结论

罂粟碱加前列腺素E1治疗阳痿优于单独使用前列腺素E1,但并发症发生率更高。海绵体内注射血管活性药物是治疗阳痿非常有效且重要的方法。罂粟碱加前列腺素E1已单独或联合用于治疗阳痿。进行了一项盲法研究,以比较海绵体内注射罂粟碱加前列腺素E1(双药溶液)与单独使用前列腺素E1的疗效和并发症发生率。

相似文献

1
Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.罂粟碱加前列腺素E1与单独使用前列腺素E1用于体内注射治疗的比较
Int Urol Nephrol. 1998;30(2):193-6. doi: 10.1007/BF02550576.
2
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.罂粟碱-酚妥拉明与前列腺素E1联合应用与单独应用罂粟碱-酚妥拉明用于体内注射治疗的临床双盲研究。
J Urol. 1995 Sep;154(3):1017-9.
3
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.海绵体内注射前列腺素E1与罂粟碱联合使用:与单独使用罂粟碱加酚妥拉明及单独使用前列腺素E1相比,效果更佳。
J Urol. 1991 Jan;145(1):56-9. doi: 10.1016/s0022-5347(17)38246-0.
4
A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.一项关于体内注射罂粟碱与前列腺素E1治疗阳痿的前瞻性双盲试验。
J Urol. 1989 Mar;141(3):551-3. doi: 10.1016/s0022-5347(17)40890-1.
5
Prostaglandin E1 therapy for impotence, comparison with papaverine.前列腺素E1治疗阳痿,与罂粟碱的比较。
J Urol. 1990 Jan;143(1):57-9. doi: 10.1016/s0022-5347(17)39864-6.
6
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.前列腺素E1与酚妥拉明/罂粟碱治疗勃起功能障碍的双盲比较
J Urol. 1989 Mar;141(3):549-50. doi: 10.1016/s0022-5347(17)40889-5.
7
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.采用双盲法评估阴茎海绵体内注射罂粟碱联合酚妥拉明和/或前列腺素E1对勃起功能的影响。
J Urol. 1992 Oct;148(4):1181-3. doi: 10.1016/s0022-5347(17)36853-2.
8
Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.比较前列腺素E1和罂粟碱治疗血管性阳痿患者的双盲交叉研究。
Urology. 1991 Jun;37(6):516-8. doi: 10.1016/0090-4295(91)80314-w.
9
Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.罂粟碱加酚妥拉明与前列腺素E1治疗勃起功能障碍的对比研究
J Urol. 1997 Jun;157(6):2132-4.
10
Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.高剂量罂粟碱加酚妥拉明无反应者中前列腺素E1与前列腺素E1、罂粟碱和酚妥拉明混合物的比较
J Urol. 1996 Mar;155(3):913-4.

引用本文的文献

1
Relaxant effect and possible mechanism of 17-nor-subincanadine E in rabbit corpora cavernosa.17-去甲-辛卡林 E 在兔阴茎海绵体中的舒张作用及其可能机制。
Asian J Androl. 2011 Sep;13(5):747-53. doi: 10.1038/aja.2011.41. Epub 2011 Jul 18.
2
Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.心血管疾病患者男性勃起功能障碍和女性性功能障碍的病因及管理
Drugs Aging. 2005;22(10):823-44. doi: 10.2165/00002512-200522100-00003.

本文引用的文献

1
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.阴茎海绵体内药物治疗勃起功能障碍:合适药物及剂量的选择。
J Urol. 1993 May;149(5 Pt 2):1288-90. doi: 10.1016/s0022-5347(17)36370-x.
2
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.罂粟碱-酚妥拉明与前列腺素E1联合应用与单独应用罂粟碱-酚妥拉明用于体内注射治疗的临床双盲研究。
J Urol. 1995 Sep;154(3):1017-9.
3
Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence.
海绵体α-阻滞剂:一种用于研究和治疗勃起功能障碍的新技术。
Br J Psychiatry. 1983 Oct;143:332-7. doi: 10.1192/bjp.143.4.332.
4
Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery.一些前列腺素在离体人阴茎勃起组织和海绵体动脉中诱导的收缩和舒张。
J Urol. 1985 Dec;134(6):1245-50. doi: 10.1016/s0022-5347(17)47704-4.
5
Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.海绵体内注射罂粟碱和酚妥拉明自我给药治疗阳痿的副作用。
J Urol. 1989 Jan;141(1):54-7. doi: 10.1016/s0022-5347(17)40585-4.
6
Why do so many people drop out from auto-injection therapy for impotence?
J Sex Marital Ther. 1989 Summer;15(2):121-9. doi: 10.1080/00926238908403816.
7
How safe is the treatment of impotence with intracavernous autoinjection?
Eur Urol. 1989;16(3):165-71. doi: 10.1159/000471562.
8
Intracavernous injection therapy: analysis of results and complications.海绵体内注射疗法:结果与并发症分析
J Urol. 1990 Jun;143(6):1138-41. doi: 10.1016/s0022-5347(17)40208-4.
9
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.海绵体内注射前列腺素E1与罂粟碱联合使用:与单独使用罂粟碱加酚妥拉明及单独使用前列腺素E1相比,效果更佳。
J Urol. 1991 Jan;145(1):56-9. doi: 10.1016/s0022-5347(17)38246-0.
10
An improved vasoactive drug combination for a pharmacological erection program.一种用于药理学勃起程序的改良血管活性药物组合。
J Urol. 1991 Dec;146(6):1564-5. doi: 10.1016/s0022-5347(17)38167-3.